19. No selectable marker is needed for this Cre-mediated excision, since 2-5% of cells are picking up the Cre expressing DNA. Practically in almost all these cells excision occurs between loxP sites placed a few kilobases apart. As a consequence, transient expression of the Cre recombinase in ES cells results in a 1 in 30 average frequency of excision.
20. If the region of DNA to be deleted contains a drug selection marker, then the newly acquired sensitivity to the marker can be tested when replica 96-well plates containing cells are available. Here, however, one should be aware of the frequent mosaic type of excision. Therefore this step does not replace the PCR or Southern blot screening.
Was this article helpful?